Bill Status of SB 1454   98th General Assembly


Short Description:  CONTROLLED SUBSTANCES-VARIOUS

Senate Sponsors
Sen. William Delgado-Andy Manar-Mattie Hunter-Donne E. Trotter-Jacqueline Y. Collins and Kyle McCarter

House Sponsors
(Rep. Daniel V. Beiser)


Last Action  View All Actions

DateChamber Action
  1/13/2015SenateSession Sine Die

Statutes Amended In Order of Appearance
New Act

Synopsis As Introduced
Creates the Internet System for Tracking Overprescribing Act. Contains only a short title provision.

Senate Committee Amendment No. 2
Deletes reference to:
New Act
Adds reference to:
720 ILCS 570/102from Ch. 56 1/2, par. 1102
720 ILCS 570/206from Ch. 56 1/2, par. 1206
720 ILCS 570/208from Ch. 56 1/2, par. 1208
720 ILCS 570/311.5
720 ILCS 570/314.5
720 ILCS 570/314.6 new
720 ILCS 570/316
720 ILCS 570/317.5 new
720 ILCS 570/319
720 ILCS 570/320
720 ILCS 570/320.5 new

Replaces everything after the enacting clause. Amends the Illinois Controlled Substances Act. Defines Prescription Monitoring Program Advisory Committee. Includes as a Schedule II controlled substance Dihydrocodeinone (Hydrocodone), with one or more active, non-narcotic ingredients in regional therapeutic amounts. Provides that as of January 1, 2015 each Schedule II prescription must be issued via electronic prescribing. All electronic prescribing must pass through the Prescription Monitoring Program portal, to establish an audit trail regarding the eventual dispensing of the medication. Provides that upon review by the Prescription Monitoring Program Advisory Committee of prescribers who have not registered as Prescription Monitoring Program users, the Committee by means of an intergovernmental agreement shall generate a file of information regarding these practitioners with consistently high numbers of patients with multiple prescribers which shall be submitted to the Department of Financial and Professional Regulation. Provides that by January 1, 2015, all Electronic Health Records Systems must interface with the Prescription Monitoring Program application program interface to insure that all providers have access to specific patient records as they are treating the patient. Provides that the Prescription Monitoring Program Advisory Committee shall report to the Director of the Division of Alcoholism and Substance abuse, the Director of Public Health, and the Secretary of the Department of Financial and Professional Regulation annually, their trended evaluation of the historic prescribing of controlled substances. Provides that as part of this report they shall make recommendations for courses of continuing professional education and other training materials for licensed health care professionals in the appropriate use of pain medications. Provides that the Prescription Monitoring Program Advisory Committee shall provide outreach and assistance to health care professional organizations to encourage and facilitate continuing medical education training programs for their members regarding appropriate prescribing practices for optimum patient care.

Senate Floor Amendment No. 3
Deletes reference to:
720 ILCS 570/311.5
720 ILCS 570/314.5
720 ILCS 570/314.6 new
720 ILCS 570/320.5 new
Adds reference to:
225 ILCS 120/40from Ch. 111, par. 8301-40

Replaces everything after the enacting clause. Amends the Wholesale Drug Distribution Licensing Act. Provides that notwithstanding any other provision of law, a distributor licensed and regulated by the Department of Financial and Professional Regulation, and registered and regulated by the United States Drug Enforcement Administration, shall be exempt from the storage, reporting, ordering, record keeping and physical security control requirements for Schedule II controlled substances with regard to any material, compound, mixture or preparation containing Hydrocodone. These Controlled Substances shall be subject to the same requirements as those imposed for Schedule III controlled substances. Amends the Illinois Controlled Substances Act. Defines Prescription Monitoring Program Advisory Committee and electronic health record. Includes as a Schedule II controlled substance Dihydrocodeinone (Hydrocodone), with one or more active, non-narcotic ingredients in regional therapeutic amounts. Provides that by January 1, 2015, all Electronic Health Records Systems should interface with the Prescription Monitoring Program application program interface to insure that all providers have access to specific patient records as they are treating the patient. Makes other changes.

Senate Floor Amendment No. 5
Deletes reference to:
720 ILCS 570/206
720 ILCS 570/208
720 ILCS 570/311.5
720 ILCS 570/314.5
720 ILCS 570/314.6 new
720 ILCS 570/320.5 new
Adds reference to:
720 ILCS 570/208.5 new

Replaces everything after the enacting clause. Amends the Wholesale Drug Distribution Licensing Act. Provides that notwithstanding any other provision of law, a distributor licensed and regulated by the Department of Financial and Professional Regulation, and registered and regulated by the United States Drug Enforcement Administration, shall be exempt from the storage, reporting, ordering, record keeping and physical security control requirements for Schedule II controlled substances with regard to any material, compound, mixture or preparation containing Hydrocodone. These Controlled Substances shall be subject to the same requirements as those imposed for Schedule III controlled substances. Amends the Illinois Controlled Substances Act. Defines Prescription Monitoring Program Advisory Committee and electronic health record. Provides that Dihydrocodeinone (Hydrocodone) with one or more active, non-narcotic ingredients in regional therapeutic amounts is a Schedule III controlled substance, subject to the requirements for prescribing of Schedule III controlled substances with the exception that any prescription must be limited to no more than a 30-day supply with any continuation requiring a new prescription. Provides that prescribers may issue multiple prescriptions (3 sequential 30-day supplies) for Dihydrocodeinone (Hydrocodone), authorizing up to a 90-day supply. Provides that by January 1, 2018, all Electronic Health Records Systems should interface with the Prescription Monitoring Program application program interface to insure that all providers have access to specific patient records as they are treating the patient. Makes other changes.

Actions 
DateChamber Action
  2/6/2013SenateFiled with Secretary by Sen. William Delgado
  2/6/2013SenateFirst Reading
  2/6/2013SenateReferred to Assignments
  3/14/2013SenateAssigned to Human Services
  3/15/2013SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. William Delgado
  3/15/2013SenateSenate Committee Amendment No. 1 Referred to Assignments
  3/19/2013SenateSenate Committee Amendment No. 1 Assignments Refers to Human Services
  3/22/2013SenateRule 2-10 Committee Deadline Established As April 19, 2013
  4/10/2013SenateSenate Committee Amendment No. 2 Filed with Secretary by Sen. William Delgado
  4/10/2013SenateSenate Committee Amendment No. 2 Referred to Assignments
  4/11/2013SenatePostponed - Human Services
  4/11/2013SenateSenate Committee Amendment No. 1 Postponed - Human Services
  4/16/2013SenateSenate Committee Amendment No. 2 Assignments Refers to Human Services
  4/16/2013SenateSenate Committee Amendment No. 2 Adopted
  4/17/2013SenateSenate Committee Amendment No. 1 Postponed - Human Services
  4/17/2013SenateDo Pass as Amended Human Services; 006-002-000
  4/17/2013SenatePlaced on Calendar Order of 2nd Reading April 18, 2013
  4/18/2013SenateSecond Reading
  4/18/2013SenatePlaced on Calendar Order of 3rd Reading April 23, 2013
  4/19/2013SenateSenate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments
  4/23/2013SenateSenate Floor Amendment No. 3 Filed with Secretary by Sen. William Delgado
  4/23/2013SenateSenate Floor Amendment No. 3 Referred to Assignments
  4/23/2013SenateSenate Floor Amendment No. 3 Assignments Refers to Human Services
  4/29/2013SenateRule 2-10 Third Reading Deadline Established As May 3, 2013
  5/2/2013SenateRule 2-10 Third Reading Deadline Established As May 31, 2013
  5/7/2013SenateSenate Floor Amendment No. 4 Filed with Secretary by Sen. William Delgado
  5/7/2013SenateSenate Floor Amendment No. 4 Referred to Assignments
  5/8/2013SenateSenate Floor Amendment No. 3 Recommend Do Adopt Human Services; 005-003-000
  5/8/2013SenateSenate Floor Amendment No. 4 Assignments Refers to Human Services
  5/15/2013SenateSenate Floor Amendment No. 5 Filed with Secretary by Sen. William Delgado
  5/15/2013SenateSenate Floor Amendment No. 5 Referred to Assignments
  5/15/2013SenateSenate Floor Amendment No. 5 Assignments Refers to Human Services
  5/17/2013SenateRecalled to Second Reading
  5/17/2013SenateSenate Floor Amendment No. 3 Adopted; Delgado
  5/17/2013SenatePlaced on Calendar Order of 3rd Reading May 20, 2013
  5/17/2013SenateAdded as Chief Co-Sponsor Sen. Andy Manar
  5/17/2013SenateSenate Floor Amendment No. 6 Filed with Secretary by Sen. William Delgado
  5/17/2013SenateSenate Floor Amendment No. 6 Referred to Assignments
  5/20/2013SenateSenate Floor Amendment No. 6 Assignments Refers to Human Services
  5/21/2013SenateAdded as Chief Co-Sponsor Sen. Mattie Hunter
  5/21/2013SenateSenate Floor Amendment No. 4 Postponed - Human Services
  5/21/2013SenateSenate Floor Amendment No. 6 Postponed - Human Services
  5/21/2013SenateSenate Floor Amendment No. 5 Recommend Do Adopt Human Services; 008-001-000
  5/22/2013SenateRecalled to Second Reading
  5/22/2013SenateSenate Floor Amendment No. 5 Adopted; Delgado
  5/22/2013SenatePlaced on Calendar Order of 3rd Reading
  5/22/2013SenateAdded as Chief Co-Sponsor Sen. Jacqueline Y. Collins
  5/22/2013SenateAdded as Chief Co-Sponsor Sen. Donne E. Trotter
  5/22/2013SenateAdded as Co-Sponsor Sen. Kyle McCarter
  5/22/2013SenateThird Reading - Passed; 033-012-004
  5/22/2013SenateSenate Committee Amendment No. 1 Tabled Pursuant to Rule 5-4(a)
  5/22/2013SenateSenate Floor Amendment No. 4 Tabled Pursuant to Rule 5-4(a)
  5/22/2013SenateSenate Floor Amendment No. 6 Tabled Pursuant to Rule 5-4(a)
  5/23/2013HouseArrived in House
  5/23/2013HouseChief House Sponsor Rep. Daniel V. Beiser
  5/23/2013HouseFirst Reading
  5/23/2013HouseReferred to Rules Committee
  5/26/2013HouseFinal Action Deadline Extended-9(b) May 31, 2013
  5/26/2013HouseAssigned to Human Services Committee
  5/28/2013HouseMoved to Suspend Rule 21 Rep. Barbara Flynn Currie
  5/28/2013HouseSuspend Rule 21 - Prevailed by Voice Vote
  5/31/2013HouseRule 19(a) / Re-referred to Rules Committee
  10/23/2013HouseAssigned to Executive Committee
  10/23/2013HouseFinal Action Deadline Extended-9(b) November 30, 2013
  11/27/2013HouseFinal Action Deadline Extended-9(b) December 20, 2013
  12/20/2013HouseRule 19(a) / Re-referred to Rules Committee
  1/13/2015SenateSession Sine Die

Back To Top